YOLFTbeta
MGI Tech Co. Ltd. A

MGI Tech Co. Ltd. A

688114 · SHG · Healthcare / Medical Devices

55.27CNY-3.53 (-6.00%)

Price History

Full chart

Market Stats

Previous Close58.80
Open58.91
Day Range55.00 – 58.91
52-Week Range44.88 – 82.88
Volume5.74M
Market Cap29.95B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.51
Dividend Yield0.00%
Beta0.32
50-Day Avg61.14
200-Day Avg57.68

About

MGI Tech Co., Ltd. engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencer products, such as DNBSEQ sequencers, cycloneSEQ sequencers, and sequencing consumables; generative lab intelligence, including sample pretreatment, nucleic acid extraction, universal pipetting, consumables, integrated platforms, intelligent digital platform, and sample preparations; and Multi-Omics, such as cell omics, STOmics, preteomics, PopOmics, sample preparation regeants, microbiomics, agriculture and food safety, public health, environment and biodiversity, ultrasound, bio-fragment analyzer, sample storage, and fluorometer products. MGI Tech Co., Ltd. was founded in 2016 and is headquartered in Shenzhen, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Feng Mou
  • Employees2.19K
  • HeadquartersComprehensive Building, Shenzhen, China, 518083, China
  • Websitehttps://en.mgi-tech.com

Leadership

  • Mr. Feng MouGeneral Manager & Director · b. 1978
  • Mr. Dejian YuPresident & Director · b. 1968
  • Mr. Bo LiuCFO & Accounting Supervisor · b. 1969
  • Ms. Hui JiangChief Operation Officer · b. 1982
  • Mr. Ming NiSenior Vice President · b. 1980
  • Mr. Jian LiuExecutive Vice President · b. 1985
  • Ms. Huanhuan PengBoard Secretary · b. 1986

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.78B3.93B4.23B2.91B3.01B2.78B
Growth (%)-+41.32%+7.69%-31.19%+3.48%-7.73%
Cost of Revenue703.70M1.32B1.96B1.30B1.34B1.31B
Gross Profit2.08B2.61B2.27B1.61B1.67B1.47B
Gross Margin74.69%66.44%53.58%55.43%55.51%52.92%
Operating Expense1.71B1.81B1.97B2.08B2.05B1.63B
Operating Income365.44M798.92M297.59M-463.29M-377.08M-163.71M
Operating Margin13.15%20.34%7.03%-15.91%-12.52%-5.89%
EBITDA--2.80B-264.87M-105.93M161.38M
EBITDA Margin--66.24%-9.10%-3.52%5.81%
Net Income260.87M483.60M2.03B-607.50M-600.83M-222.14M
Net Income Margin9.38%12.31%47.90%-20.87%-19.94%-7.99%
R&D700.14M608.30M814.37M909.98M746.31M538.93M
R&D as % of Total Revenue25.19%15.48%19.25%31.26%24.77%19.39%
Interest Expense82.84M21.36M8.57M13.41M23.66M28.76M
Interest Expense % of Total Revenue2.98%0.54%0.20%0.46%0.79%1.03%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-6.18B5.94B11.22B10.56B10.31B10.20B
Total Liabilities-2.63B1.87B1.77B1.88B2.42B2.55B
Total Equity-3.48B4.01B9.41B8.63B7.89B7.65B
Cash-2.79B2.61B6.48B4.78B2.28B2.80B
Net Debt1.15B------

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.74M1.07B1.42B-870.08M-774.40M218.98M
Capital Expenditure497.82M317.06M938.42M758.10M385.05M194.49M
Free Cash Flow-493.07M756.13M482.83M-1.63B-1.16B24.49M
Dividends Paid76.58M13.86M255.95K155.82M24.17M19.81M
FCF to OCF-10394.32%70.46%33.97%187.13%149.72%11.18%
Dividend Paid to FCF-15.53%1.83%0.05%-9.57%-2.08%80.91%

Earnings

Report DateOct 19, 2022Feb 24, 2023Apr 24, 2023Aug 10, 2023Oct 27, 2023Feb 28, 2024Apr 25, 2024Aug 23, 2024Oct 30, 2024Feb 27, 2025Apr 29, 2025Aug 22, 2025Oct 23, 2025Feb 27, 2026Apr 24, 2026Aug 21, 2026
EPS Estimate0.331.510.37-0.12-0.10-1.030.01--0.24-0.08-0.08-0.11-0.07-0.010.04-0.08
EPS Actual0.02-0.14-0.250.07-0.24-0.96-0.49-0.23-0.40-0.32-0.330.07-0.04-0.29-0.26-0.12
Surprise-93.94%-109.27%-167.57%158.33%-140.00%6.80%-5000.00%--66.67%-300.00%-312.50%163.64%42.86%-2800.00%-750.00%-50.00%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap29.95B
Enterprise Value27.32B
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.99
Price / Book4.46
EPS-0.51
Book Value17.09
Revenue (TTM)3.00B
Gross Profit (TTM)1.47B
EBITDA216.43M
Profit Margin-7.05%
Operating Margin-5.00%
Return on Equity-2.85%
Return on Assets-0.79%
Shares Outstanding416.52M
Shares Float172.58M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.36Jul 10, 2023